Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph Aisner, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Jersey Oncology Center, Pa - East Brunswick
East Brunswick, New Jersey, United States
- Jfk Medical Center in Edison
Edison, New Jersey, United States
- Centrastate Medical Center
Freehold, New Jersey, United States
- Cancer Institute of New Jersey at Hamilton
Hamilton, New Jersey, United States
- Monmouth Medical Center
Long Branch, New Jersey, United States
- Mountainside Hospital Cancer Center
Montclair, New Jersey, United States
- Jersey Shore University Medical Center
Neptune City, New Jersey, United States
- Cancer Institute of New Jersey at Umdnj - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Saint Peter'S University Hospital
New Brunswick, New Jersey, United States
- Umdnj - University Hospital
Newark, New Jersey, United States
- Raritan Bay Medical Center
Perth Amboy, New Jersey, United States
- Somerset Medical Center
Somerville, New Jersey, United States
- Overlook Hospital
Summit, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 28 Feb 2010
- Completion
- 28 Feb 2010
- Last update posted
- 15 Aug 2023
- Registered enrollment
- 49
- Registry id
- NCT00118131
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.